Loading stock data…
WST
$322.30-3.62 (-1.11%)
Pre-Market$318.00-4.30 (-1.33%)· Last close May 11
West Pharmaceutical Services, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
West Pharmaceutical Services, Inc. in the Healthcare sector is trading at $322.30. The stock is currently near its 52-week high of $330.88, remaining 23.3% above its 200-day moving average. Technical signals show overbought RSI of 76 and bullish MACD crossover, explaining why WST maintains its current momentum and trend strength. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 76) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$322.30
Potential Downside
47.9%
Whystock Fair Value$168.04
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Buy
Mean target$349.85+8.5%
Range$310.00 – $400.00
Fundamentals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Pro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$19.78B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
40.41
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.15
Div Yield
Strong income play. Yield provides a meaningful total return floor.
32.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.36%
Volume
Today's trading volume
683,583
Recent News
ALGN vs. WST: Which Stock Is the Better Value Option?
ALGN vs. WST: Which Stock Is the Better Value Option?
GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning
GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.
West Pharmaceutical Services, Inc. (WST) Hit a 52 Week High, Can the Run Continue?
West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum
Stock performance snapshot and business context West Pharmaceutical Services (WST) has drawn fresh attention after recent share price moves, with the stock last closing at $322.01 and showing double digit total returns over the past year. For readers tracking consistency, the stock shows positive total returns over the past week, month and past 3 months, alongside a reported 1 year total return of 50.448% and a 3 year total return of a 9.823% decline. Over 5 years, total return is described...
AMN Q1 Earnings & Revenues Beat Estimates, Gross Margin Contracts
AMN Healthcare posts 367% adjusted EPS growth in Q1 as labor disruption demand and staffing gains drive revenues past estimates.